AGP Executive Report
Last update: 9 hours agoRare-disease drug update: AFT Pharmaceuticals says the US FDA has issued tentative approval for Scomara (rapamycin 0.5% cream) to treat facial angiofibromas in tuberous sclerosis, with launch tied to existing orphan exclusivity. Public health enforcement: Hong Kong’s Tobacco and Alcohol Control Office ran “Thunderstone” to crack down on illegal online sales of alternative smoking products, seizing 800 suspected items and stopping a 20-year-old man for investigation. Women’s reproductive health: Sow Fertility founder and CEO Dawn Chan was named a Tatler Gen.T Leader of Tomorrow 2026 for work aimed at closing the support gap in women’s reproductive health. Blood management tech: Haier Biomedical showcased an integrated digital blood management workflow at ISBT Congress 2026, positioning itself as a full-process solution provider for plasma collection, storage and clinical use. Antibiotic resistance warning: A large global study reports rising antimicrobial resistance in children across 82 countries, with resistance increasing in every region from 2004–2022 and threatening effectiveness of key antibiotics. Care access & governance: Objective Corporation partnered with Hong Kong non-profit ImpactHK to use Objective Connect for more secure, centralised case management for people experiencing homelessness.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
